ClinicalThought

Share

Program Content

Activities

  • Optimal Treatment of CLL
    Expert Answers to Questions Regarding the Optimal Treatment of CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 21, 2025

    Expires: January 20, 2026

Faculty

cover img faculity

Danielle M. Brander, MD

Associate Professor of Medicine
Division of Hematologic Malignancies and Cellular Therapy
Department of Medicine, Duke University
Director, CLL/Lymphoma Research
Duke Cancer Institute
Durham, North Carolina

cover img faculity

Brian Hill, MD, PhD

Director, Lymphoid Malignancies Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Sameer A. Parikh, MBBS

Consultant, Division of Hematology
Chair, CLL Disease Team
Vice Chair, Lymphoid Malignancies Disease Group
Mayo Clinic Comprehensive Cancer Center
Associate Professor of Medicine
Assistant Professor of Oncology
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, BeiGene, and Lilly.

AstraZeneca

BeiGene

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner